These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


260 related items for PubMed ID: 9915812

  • 1. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor. Structure-activity relationship of 2-arachidonoylglycerol, ether-linked analogues, and related compounds.
    Sugiura T, Kodaka T, Nakane S, Miyashita T, Kondo S, Suhara Y, Takayama H, Waku K, Seki C, Baba N, Ishima Y.
    J Biol Chem; 1999 Jan 29; 274(5):2794-801. PubMed ID: 9915812
    [Abstract] [Full Text] [Related]

  • 2. Evidence that 2-arachidonoylglycerol but not N-palmitoylethanolamine or anandamide is the physiological ligand for the cannabinoid CB2 receptor. Comparison of the agonistic activities of various cannabinoid receptor ligands in HL-60 cells.
    Sugiura T, Kondo S, Kishimoto S, Miyashita T, Nakane S, Kodaka T, Suhara Y, Takayama H, Waku K.
    J Biol Chem; 2000 Jan 07; 275(1):605-12. PubMed ID: 10617657
    [Abstract] [Full Text] [Related]

  • 3. 2-Arachidonoylglycerol, a putative endogenous cannabinoid receptor ligand, induces rapid, transient elevation of intracellular free Ca2+ in neuroblastoma x glioma hybrid NG108-15 cells.
    Sugiura T, Kodaka T, Kondo S, Tonegawa T, Nakane S, Kishimoto S, Yamashita A, Waku K.
    Biochem Biophys Res Commun; 1996 Dec 04; 229(1):58-64. PubMed ID: 8954083
    [Abstract] [Full Text] [Related]

  • 4. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development.
    Yang ZM, Paria BC, Dey SK.
    Biol Reprod; 1996 Oct 04; 55(4):756-61. PubMed ID: 8879486
    [Abstract] [Full Text] [Related]

  • 5. Internalization and recycling of the CB1 cannabinoid receptor.
    Hsieh C, Brown S, Derleth C, Mackie K.
    J Neurochem; 1999 Aug 04; 73(2):493-501. PubMed ID: 10428044
    [Abstract] [Full Text] [Related]

  • 6. Modulation of electrically evoked acetylcholine release through cannabinoid CB1 receptors: evidence for an endocannabinoid tone in the human neocortex.
    Steffens M, Szabo B, Klar M, Rominger A, Zentner J, Feuerstein TJ.
    Neuroscience; 2003 Aug 04; 120(2):455-65. PubMed ID: 12890515
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of long-term potentiation in rat hippocampal slices by anandamide and WIN55212-2: reversal by SR141716 A, a selective antagonist of CB1 cannabinoid receptors.
    Terranova JP, Michaud JC, Le Fur G, Soubrié P.
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov 04; 352(5):576-9. PubMed ID: 8751088
    [Abstract] [Full Text] [Related]

  • 8. A peripheral mechanism for CB1 cannabinoid receptor-dependent modulation of feeding.
    Gómez R, Navarro M, Ferrer B, Trigo JM, Bilbao A, Del Arco I, Cippitelli A, Nava F, Piomelli D, Rodríguez de Fonseca F.
    J Neurosci; 2002 Nov 01; 22(21):9612-7. PubMed ID: 12417686
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors.
    Járai Z, Wagner JA, Varga K, Lake KD, Compton DR, Martin BR, Zimmer AM, Bonner TI, Buckley NE, Mezey E, Razdan RK, Zimmer A, Kunos G.
    Proc Natl Acad Sci U S A; 1999 Nov 23; 96(24):14136-41. PubMed ID: 10570211
    [Abstract] [Full Text] [Related]

  • 11. A synthetic cannabinoid, CP55940, inhibits lipopolysaccharide-induced cytokine mRNA expression in a cannabinoid receptor-independent mechanism in rat cerebellar granule cells.
    Chiba T, Ueno S, Obara Y, Nakahata N.
    J Pharm Pharmacol; 2011 May 23; 63(5):636-47. PubMed ID: 21492165
    [Abstract] [Full Text] [Related]

  • 12. The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.
    Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Ségui M, Casellas P.
    FEBS Lett; 1998 Apr 03; 425(3):419-25. PubMed ID: 9563506
    [Abstract] [Full Text] [Related]

  • 13. Synthesis and biological activities of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, and its metabolically stable ether-linked analogues.
    Suhara Y, Takayama H, Nakane S, Miyashita T, Waku K, Sugiura T.
    Chem Pharm Bull (Tokyo); 2000 Jul 03; 48(7):903-7. PubMed ID: 10923815
    [Abstract] [Full Text] [Related]

  • 14. Anandamide and WIN 55212-2 inhibit cyclic AMP formation through G-protein-coupled receptors distinct from CB1 cannabinoid receptors in cultured astrocytes.
    Sagan S, Venance L, Torrens Y, Cordier J, Glowinski J, Giaume C.
    Eur J Neurosci; 1999 Feb 03; 11(2):691-9. PubMed ID: 10051770
    [Abstract] [Full Text] [Related]

  • 15. O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus.
    Jergas B, Schulte K, Bindila L, Lutz B, Schlicker E.
    Naunyn Schmiedebergs Arch Pharmacol; 2014 Jul 03; 387(7):621-8. PubMed ID: 24853577
    [Abstract] [Full Text] [Related]

  • 16. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses.
    Wilson RI, Nicoll RA.
    Nature; 2001 Mar 29; 410(6828):588-92. PubMed ID: 11279497
    [Abstract] [Full Text] [Related]

  • 17. Cannabinoids inhibit sodium-dependent, high-affinity excitatory amino acid transport in cultured rat cortical astrocytes.
    Shivachar AC.
    Biochem Pharmacol; 2007 Jun 15; 73(12):2004-11. PubMed ID: 17445778
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
    Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS.
    Eur J Pharmacol; 2003 Jan 10; 459(1):83-95. PubMed ID: 12505537
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.